These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 27157296

  • 1. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
    Paik JH, Choe JY, Kim H, Lee JO, Kang HJ, Shin HY, Lee DS, Heo DS, Kim CW, Cho KH, Kim TM, Jeon YK.
    Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
    [Abstract] [Full Text] [Related]

  • 2. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
    Wang RC, Chang ST, Hsieh YC, Huang WT, Hsu JD, Tseng CE, Wang MC, Hwang WS, Wang J, Chuang SS.
    Int J Clin Exp Pathol; 2014 Jan; 7(5):2430-7. PubMed ID: 24966953
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
    Guo N, Chen Y, Wang Y, Huang Y, Feng Y, Li M, Rao H.
    Diagn Pathol; 2019 Jul 17; 14(1):82. PubMed ID: 31315684
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
    Hue SS, Oon ML, Wang S, Tan SY, Ng SB.
    Pathology; 2020 Jan 17; 52(1):111-127. PubMed ID: 31767131
    [Abstract] [Full Text] [Related]

  • 5. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M.
    Int J Oncol; 2004 May 17; 24(5):1165-74. PubMed ID: 15067338
    [Abstract] [Full Text] [Related]

  • 6. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY, Baek JO, Lee JR, Park SH, Jeon IS, Roh JY.
    Am J Dermatopathol; 2012 Dec 17; 34(8):e119-24. PubMed ID: 23169419
    [Abstract] [Full Text] [Related]

  • 7. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With SH2D1A/XIAP Hypomorphic Gene Variants.
    Ishimura M, Eguchi K, Shiraishi A, Sonoda M, Azuma Y, Yamamoto H, Imadome KI, Ohga S.
    Front Pediatr; 2019 Dec 17; 7():183. PubMed ID: 31231620
    [Abstract] [Full Text] [Related]

  • 8. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S, Ishimura M, Yoshimoto G, Miyamoto T, Takada H, Tanaka T, Ohshima K, Ogawa Y, Imadome K, Abe Y, Akashi K, Hara T.
    J Clin Virol; 2011 May 17; 51(1):31-7. PubMed ID: 21377409
    [Abstract] [Full Text] [Related]

  • 9. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.
    Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, Naoe T, Esaki S, Kikuta A, Sawada A, Kawa K, Ohshima K, Nakamura S.
    Blood; 2012 Jan 19; 119(3):673-86. PubMed ID: 22096243
    [Abstract] [Full Text] [Related]

  • 10. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
    Iwatsuki K, Miyake T, Hirai Y, Yamamoto T.
    Eur J Dermatol; 2019 Feb 01; 29(1):21-28. PubMed ID: 30998212
    [Abstract] [Full Text] [Related]

  • 11. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
    Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK, CAEBV Study Group.
    Pathol Int; 2008 Apr 01; 58(4):209-17. PubMed ID: 18324913
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.
    Hirai Y, Asada H, Hamada T, Kawada JI, Kimura H, Arai A, Ohshima K, Ohga S, Iwatsuki K, Committee for Guidelines for the Management of Chronic Active EBV Disease and Related Disorders (the MHLW Research Team in Japan).
    J Dermatol; 2023 Jul 01; 50(7):e198-e205. PubMed ID: 37249004
    [Abstract] [Full Text] [Related]

  • 13. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China.
    Wang X, Liang Y, Yang Y, Li W, Wang G, Wang S, Li Y, Zhang M.
    J Dermatol; 2021 Sep 01; 48(9):1315-1326. PubMed ID: 33982815
    [Abstract] [Full Text] [Related]

  • 14. Somatic mutations in KMT2D and TET2 associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders.
    Gao LM, Zhao S, Zhang WY, Wang M, Li HF, Lizaso A, Liu WP.
    Cancer Biol Ther; 2019 Sep 01; 20(10):1319-1327. PubMed ID: 31311407
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
    Park S, Ko YH.
    J Dermatol; 2014 Jan 01; 41(1):29-39. PubMed ID: 24438142
    [Abstract] [Full Text] [Related]

  • 16. A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.
    Kawamoto K, Miyoshi H, Suzuki T, Kozai Y, Kato K, Miyahara M, Yujiri T, Choi I, Fujimaki K, Muta T, Kume M, Moriguchi S, Tamura S, Kato T, Tagawa H, Makiyama J, Kanisawa Y, Sasaki Y, Kurita D, Yamada K, Shimono J, Sone H, Takizawa J, Seto M, Kimura H, Ohshima K.
    Haematologica; 2018 Jun 01; 103(6):1018-1028. PubMed ID: 29242302
    [Abstract] [Full Text] [Related]

  • 17. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
    Zhang Y, Nagata H, Ikeuchi T, Mukai H, Oyoshi MK, Demachi A, Morio T, Wakiguchi H, Kimura N, Shimizu N, Yamamoto K.
    Br J Haematol; 2003 Jun 01; 121(5):805-14. PubMed ID: 12780797
    [Abstract] [Full Text] [Related]

  • 18. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
    Montes-Mojarro IA, Kim WY, Fend F, Quintanilla-Martinez L.
    Semin Diagn Pathol; 2020 Jan 01; 37(1):32-46. PubMed ID: 31889602
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E, Ohshima K, Kimura H, Hara K, Suzuki R, Kawa K, Eimoto T, Nakamura S, NK-cell Tumor Study Group.
    Histopathology; 2011 Oct 01; 59(4):660-71. PubMed ID: 22014047
    [Abstract] [Full Text] [Related]

  • 20. Inherited Genetic Susceptibility to Nonimmunosuppressed Epstein-Barr Virus-associated T/NK-cell Lymphoproliferative Diseases in Chinese Patients.
    Guan YQ, Shen KF, Yang L, Cai HD, Zhang ML, Wang JC, Long XL, Xiong J, Gu J, Zhang PL, Xiao M, Zhang W, Zhou JF.
    Curr Med Sci; 2021 Jun 01; 41(3):482-490. PubMed ID: 34170459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.